| Identifying the best machine learning algorithms for brain tumor segmentation, progression assessment, and overall survival prediction in the BRATS challenge S Bakas, M Reyes, A Jakab, S Bauer, M Rempfler, A Crimi, RT Shinohara, ... arXiv preprint arXiv:1811.02629, 2018 | 1619 | 2018 |
| The rsna-asnr-miccai brats 2021 benchmark on brain tumor segmentation and radiogenomic classification U Baid, S Ghodasara, S Mohan, M Bilello, E Calabrese, E Colak, ... arXiv preprint arXiv:2107.02314, 2021 | 361 | 2021 |
| Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. H Fathallah-Shaykh, S Wolf, E Wong, JB Posner, HM Furneaux Proceedings of the National Academy of Sciences 88 (8), 3451-3454, 1991 | 170 | 1991 |
| Gene transfer of IFN-γ into established brain tumors represses growth by antiangiogenesis HM Fathallah-Shaykh, LJ Zhao, AI Kafrouni, GM Smith, J Forman The Journal of Immunology 164 (1), 217-222, 2000 | 116 | 2000 |
| Identifying the best machine learning algorithms for brain tumor segmentation S Bakas, M Reyes, A Jakab, S Bauer, M Rempfler, A Crimi, RT Shinohara, ... progression assessment, and overall survival prediction in the BRATS …, 2018 | 105 | 2018 |
| Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro X Han, R Li, W Zhang, X Yang, CG Wheeler, GK Friedman, P Province, ... Journal of neuro-oncology 118, 61-72, 2014 | 97 | 2014 |
| Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome JM Grunda, J Fiveash, CA Palmer, A Cantor, HM Fathallah-Shaykh, ... Clinical cancer research 16 (10), 2890-2898, 2010 | 80 | 2010 |
| A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma LB Nabors, JB Fiveash, JM Markert, MS Kekan, GY Gillespie, Z Huang, ... Archives of neurology 67 (3), 313-319, 2010 | 77 | 2010 |
| Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma PY Wen, A Omuro, MS Ahluwalia, HM Fathallah-Shaykh, N Mohile, ... Neuro-oncology 17 (9), 1275-1283, 2015 | 70 | 2015 |
| A multilayer grow-or-go model for GBM: effects of invasive cells and anti-angiogenesis on growth O Saut, JB Lagaert, T Colin, HM Fathallah-Shaykh Bulletin of mathematical biology 76, 2306-2333, 2014 | 68 | 2014 |
| The role of Src family kinases in growth and migration of glioma stem cells X Han, W Zhang, X Yang, CG Wheeler, CP Langford, L Wu, N Filippova, ... International journal of oncology 45 (1), 302-310, 2014 | 68 | 2014 |
| Optic neuropathy in patients with glioblastoma receiving bevacizumab JH Sherman, DG Aregawi, A Lai, HM Fathallah-Shaykh, PJ Bierman, ... Neurology 73 (22), 1924-1926, 2009 | 56 | 2009 |
| Gene expression analysis in radiotherapy patients and C57BL/6 mice as a measure of exposure to ionizing radiation AN Filiano, HM Fathallah-Shaykh, J Fiveash, J Gage, A Cantor, ... Radiation research 176 (1), 49-61, 2011 | 53 | 2011 |
| The federated tumor segmentation (fets) challenge S Pati, U Baid, M Zenk, B Edwards, M Sheller, GA Reina, P Foley, ... arXiv preprint arXiv:2105.05874, 2021 | 51 | 2021 |
| Microarrays: applications and pitfalls HM Fathallah-Shaykh Archives of neurology 62 (11), 1669-1672, 2005 | 50 | 2005 |
| Inception modules enhance brain tumor segmentation DE Cahall, G Rasool, NC Bouaynaya, HM Fathallah-Shaykh Frontiers in computational neuroscience 13, 44, 2019 | 49 | 2019 |
| Priming in the brain, an immunologically privileged organ, elicits anti‐tumor immunity HM Fathallah‐Shaykh, W Gao, M Cho, MA Herrera International journal of cancer 75 (2), 266-276, 1998 | 48 | 1998 |
| Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiforme CE Griguer, AB Cantor, HM Fathallah-Shaykh, GY Gillespie, AS Gordon, ... PloS one 8 (4), e61035, 2013 | 46 | 2013 |
| Genomic expression discovery predicts pathways and opposing functions behind phenotypes HM Fathallah-Shaykh, B He, LJ Zhao, HH Engelhard, L Cerullo, T Lichtor, ... Journal of Biological Chemistry 278 (26), 23830-23833, 2003 | 45 | 2003 |
| Survival in a transgenic model of FALS is independent of iNOS expression M Son, HM Fathallah‐Shaykh, JL Elliott Annals of Neurology 50 (2), 273-273, 2001 | 39 | 2001 |
Nidhal Carla BouaynayaRowan UniversityVerified email at rowan.edu
